Dr. Howard Schubiner Reviews & Criticism: An Evidence Check

Published August 23, 2026 · 9 min read

By Tauri Urbanik, research writer and PainApp founder

What this review does—and does not—measure

People searching for “Dr. Howard Schubiner reviews” may be asking three different questions:

1. Are his credentials real? This can be checked against institutional affiliations and peer-reviewed publications.
2. Is the treatment model supported? This requires examining trials of PRT, EAET, and related approaches—not counting testimonials.
3. Will it work for me? No review page can answer that. Fit depends on the pain mechanism, medical context, clinician, delivery format, and the person receiving care.

We do not publish an invented star rating or combine anonymous testimonials into a fake success rate. Patient stories can help readers understand an experience, but they are vulnerable to selection effects and cannot show what happens on average.

Credentials: what can be verified

Schubiner is a physician and clinical researcher. Recent peer-reviewed papers list him with the Department of Internal Medicine at Michigan State University. His published work includes chronic primary pain assessment, PRT, and EAET (Schubiner et al., The Journal of Pain, 2024↗).

That establishes relevant training and research participation. It should not be stretched into an endorsement of every claim made by a course, book, interview, clinic, or third-party practitioner using similar language.

Readers using his self-guided program can pair our full Unlearn Your Pain review with the practical workbook and meditations companion. Those resources distinguish the published treatment evidence from claims about the book itself.

Evidence review: three separate questions

Chronic primary pain assessment

The 2024 clinic study used a two-stage approach: first examine possible nociceptive or neuropathic explanations, then look for a pattern that could support chronic primary pain. Features associated with the primary-pain classification included spreading pain, sensitivity to light touch, and stress-linked worsening. Almost every participant had at least one imaging abnormality, so imaging findings alone did not determine the classification (Schubiner et al., The Journal of Pain, 2024↗).

This is clinically interesting, not a validated home diagnosis. The classification was applied in one community physiatry clinic, and the paper explicitly states that refinement and validation are still needed.

Pain Reprocessing Therapy

Schubiner was a coauthor of the randomized PRT trial in 151 adults with primary chronic back pain. The PRT group received one physician session and eight psychological-treatment sessions over four weeks. At the post-treatment endpoint, 33 of 50 participants assigned to PRT reported pain scores of zero or one, compared with 10 of 51 assigned to placebo and 5 of 50 receiving usual care (Ashar et al., JAMA Psychiatry, 2022↗).

That is a notable result. It is not Schubiner's personal patient success rate, does not apply automatically to other pain conditions, and does not make an app, book, or unstructured coaching equivalent to the therapist-led protocol.

Emotional Awareness and Expression Therapy

In a 230-person fibromyalgia trial, EAET did not differ from education on the primary outcome of pain severity. It did improve several secondary outcomes versus education. Compared with CBT, most outcomes did not differ, although some symptom and pain outcomes favored EAET (Lumley et al., Pain, 2017↗).

A later VA trial in 126 older adults found EAET superior to CBT for its primary pain-severity outcome at post-treatment and six months (Yarns et al., JAMA Network Open, 2024↗). The result strengthens the case for EAET while leaving open how well it transfers to younger, more gender-diverse, and non-veteran populations.

The strongest reasonable criticisms

1. The diagnostic language can sound more certain than the evidence

“TMS,” “neural circuit pain,” “neuroplastic pain,” “nociplastic pain,” and “chronic primary pain” overlap, but they are not interchangeable in every clinical or research context. The International Association for the Study of Pain defines nociplastic pain as pain arising from altered nociception without clear evidence that nociceptive or neuropathic mechanisms fully explain it; mixed mechanisms can coexist (International Association for the Study of Pain, IASP Terminology↗).

2. Positive trials can be overgeneralized

The strongest PRT randomized evidence is for selected adults with primary chronic back pain. EAET has evidence in several populations, but results and comparators differ. Neither evidence base justifies telling every person with persistent pain that tissue, nerve, inflammatory, or disease-related contributors are irrelevant.

3. Testimonials obscure denominator and selection

A striking recovery story says nothing about how many people tried the same program, stopped, worsened, improved partly, or received other care at the same time. Look for population, comparator, outcome definition, follow-up, and attrition before treating a number as evidence.

4. Emotional work is not a universal requirement

Some people value expressive writing or emotion-focused therapy. Others benefit from pain education, graded activity, CBT, ACT, medication, rehabilitation, condition-specific treatment, or a combination. Lack of a dramatic emotional story does not disprove a nociplastic contributor, and emotional stress does not prove one.

Who might reasonably explore the approach?

It may be worth discussing with a qualified clinician when:

• symptoms have persisted after appropriate assessment;
• the pain pattern is variable, widespread, stress-responsive, or difficult to explain with one peripheral finding;
• fear, avoidance, or symptom monitoring has become a major part of the disability;
• the person understands that mind-body treatment complements rather than erases medical care;
• the provider is licensed for the service they offer and stays within scope.

Seek medical assessment instead of relying on a program review when symptoms are new, rapidly changing, associated with neurological loss, systemic illness, significant trauma, or another concerning feature.

Questions to ask before paying

• What is your professional license, and where may you legally treat me?
• Which treatment are you offering: PRT, EAET, CBT, coaching, education, or a blend?
• How do you screen for nociceptive, neuropathic, inflammatory, and mixed contributors?
• What outcomes do you track besides pain intensity?
• What happens if symptoms worsen or the working formulation changes?
• What is the total expected cost, cancellation policy, and insurance arrangement?
• Which claims come from trials, and which come from your own observations?

For a lower-cost starting point, compare the Unlearn Your Pain review with the PRT cost and access guide. A self-guided resource can teach concepts, but it is not individualized diagnosis or psychotherapy.

Frequently asked questions

Is Dr. Howard Schubiner a legitimate physician?

Yes. Published research identifies Howard Schubiner, MD, as an internal-medicine physician affiliated with Michigan State University. Legitimacy of credentials does not mean every claim, program, or treatment will fit every patient.

Are reviews of Howard Schubiner proof that his method works?

No. Testimonials describe individual experiences but cannot establish average benefit, harms, or who is likely to respond. Randomized trials of PRT and EAET are more useful, although they test treatment packages in selected populations rather than one clinician's personal success rate.

What is the strongest criticism of Schubiner's approach?

The main evidence-based concern is overgeneralization: positive trials in selected chronic-pain populations do not show that every persistent symptom is neuroplastic or that one approach is superior for every condition. Medical assessment and differential diagnosis still matter.

Is Unlearn Your Pain worth trying?

It may be a reasonable low-cost educational option for someone whose symptoms have been appropriately assessed and who wants structured mind-body exercises. It is not a diagnostic test, emergency care, or a substitute for individualized treatment when symptoms are new, progressive, or medically unexplained.

References

1. Schubiner H, et al. Application of a Clinical Approach to Diagnosing Primary Pain: Prevalence and Correlates of Primary Back and Neck Pain in a Community Physiatry Clinic. J Pain. 2024;25(3):672-681.DOI: 10.1016/j.jpain.2023.09.019
2. Ashar YK, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):13-23.DOI: 10.1001/jamapsychiatry.2021.2669
3. Lumley MA, et al. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. Pain. 2017;158(12):2354-2363.DOI: 10.1097/j.pain.0000000000001036
4. Yarns BC, et al. Emotional Awareness and Expression Therapy vs Cognitive Behavioral Therapy for Chronic Pain in Older Veterans: A Randomized Clinical Trial. JAMA Network Open. 2024;7(6):e2415842.DOI: 10.1001/jamanetworkopen.2024.15842
5. International Association for the Study of Pain. Terminology: nociplastic pain.